The Cancer Epigenetics Institute (CEI) at Fox Chase is a national hub for epigenetics study and collaboration that is focused on mechanisms promoting cancer and therapeutic resistance. CEI aims to promote fundamental discovery in cancer epigenetics, while identifying novel biomarkers and therapeutic targets. Its mission is to translate these scientific insights into a positive impact on patients by facilitating academic-to-industry and academic-to-academic partnerships. Virtual option is available.
Keynote Address:
Peter Jones, PhD, D. Sc (hon)
Chief Scientific Officer
Director, Van Andel Institute
Confirmed Speakers:
- Dr. Omar Abel-Wahab (MSKCC)
- Dr. Cheryl Arrowsmith (University of Toronto)
- Dr. Emily Bernstein (Ichan School of Medicine at Mount Sinal)
- Dr. Gozani (Stanford University)
- Dr. Cigall Kadoch (HHMI/Harvard Medical School)
- Dr. Tatiana Kutateladze (University of Colorado)
- Dr. Chris Mason (Weill Cornell Medicine)